Roles of Proteolysis and Lipid Rafts in the Processing of the Amyloid Precursor Protein and Prion Protein
Overview
Authors
Affiliations
In the amyloidogenic pathway, the APP (amyloid precursor protein) is proteolytically processed by the beta- and gamma-secretases to release the Abeta (amyloid-beta) peptide that is neurotoxic and aggregates in the brains of patients suffering from Alzheimer's disease. In the non-amyloidogenic pathway, APP is cleaved by alpha-secretase within the Abeta domain, precluding deposition of intact Abeta peptide. The cellular form of the PrP(C) (prion protein) undergoes reactive oxygen species-mediated beta-cleavage within the copper-binding octapeptide repeats or, alternatively, alpha-cleavage within the central hydrophobic neurotoxic domain. In addition, PrP(C) is shed from the membrane by the action of a zinc metalloprotease. Members of the ADAM (a disintegrin and metalloproteinase) family of zinc metalloproteases, notably ADAM10 and TACE (ADAM17) display alpha-secretase activity towards APP and appear to be responsible for the alpha-cleavage of PrP(C). The amyloidogenic cleavage of APP by the beta- and gamma-secretases appears to occur preferentially in cholesterol-rich lipid rafts, while the conversion of PrP(C) into the infectious form PrP(Sc) also appears to occur in these membrane domains.
Rodriguez-Vazquez M, Falconi J, Heron-Milhavet L, Lassus P, Geminard C, Djiane A EMBO Rep. 2024; 25(10):4410-4432.
PMID: 39251827 PMC: 11467327. DOI: 10.1038/s44319-024-00241-3.
The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities.
Brandimarti R, Irollo E, Meucci O Mol Neurobiol. 2022; 60(4):1811-1825.
PMID: 36576708 PMC: 9984340. DOI: 10.1007/s12035-022-03153-2.
Fu Y, Wang Z, Huang L, Tan C, Cao X, Tan L Front Aging Neurosci. 2022; 14:1008780.
PMID: 36299612 PMC: 9588952. DOI: 10.3389/fnagi.2022.1008780.
Structure-Activity Relationship of Carbon Nitride Dots in Inhibiting Tau Aggregation.
Zhou Y, Kandel N, Bartoli M, Serafim L, ElMetwally A, Falkenberg S Carbon N Y. 2022; 193:1-16.
PMID: 35463198 PMC: 9030089. DOI: 10.1016/j.carbon.2022.03.021.
Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance.
Loh D, Reiter R Molecules. 2022; 27(3).
PMID: 35163973 PMC: 8839844. DOI: 10.3390/molecules27030705.